These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 27483449)
21. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis. Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655 [TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185 [TBL] [Abstract][Full Text] [Related]
23. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting. van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716 [TBL] [Abstract][Full Text] [Related]
24. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286 [TBL] [Abstract][Full Text] [Related]
25. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. van de Stadt LA; de Koning MH; van de Stadt RJ; Wolbink G; Dijkmans BA; Hamann D; van Schaardenburg D Arthritis Rheum; 2011 Nov; 63(11):3226-33. PubMed ID: 21792832 [TBL] [Abstract][Full Text] [Related]
26. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls. Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484 [TBL] [Abstract][Full Text] [Related]
27. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis. Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390 [TBL] [Abstract][Full Text] [Related]
28. Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission. Pelzek AJ; Grönwall C; Rosenthal P; Greenberg JD; McGeachy M; Moreland L; Rigby WFC; Silverman GJ Arthritis Rheumatol; 2017 Jun; 69(6):1176-1186. PubMed ID: 28118534 [TBL] [Abstract][Full Text] [Related]
29. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients. Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876 [TBL] [Abstract][Full Text] [Related]
30. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies. Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655 [TBL] [Abstract][Full Text] [Related]
31. Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis. Brink M; Ljung L; Hansson M; Rönnelid J; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S Rheumatology (Oxford); 2022 Nov; 61(12):4985-4990. PubMed ID: 35532073 [TBL] [Abstract][Full Text] [Related]
32. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis. Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911 [TBL] [Abstract][Full Text] [Related]
33. The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis. Van Steendam K; Tilleman K; Deforce D Rheumatology (Oxford); 2011 May; 50(5):830-7. PubMed ID: 21278075 [TBL] [Abstract][Full Text] [Related]
34. Association of Distinct Fine Specificities of Anti-Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis. Schwenzer A; Quirke AM; Marzeda AM; Wong A; Montgomery AB; Sayles HR; Eick S; Gawron K; Chomyszyn-Gajewska M; Łazarz-Bartyzel K; Davis S; Potempa J; Kessler BM; Fischer R; Venables PJ; Payne JB; Mikuls TR; Midwood KS Arthritis Rheumatol; 2017 Dec; 69(12):2303-2313. PubMed ID: 29084415 [TBL] [Abstract][Full Text] [Related]
35. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis. Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Sköld M; Grunewald J; Chatzidionysiou K; Catrina A RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917833 [TBL] [Abstract][Full Text] [Related]
36. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. van der Woude D; Rantapää-Dahlqvist S; Ioan-Facsinay A; Onnekink C; Schwarte CM; Verpoort KN; Drijfhout JW; Huizinga TW; Toes RE; Pruijn GJ Ann Rheum Dis; 2010 Aug; 69(8):1554-61. PubMed ID: 20448290 [TBL] [Abstract][Full Text] [Related]
37. The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA. Suwannalai P; Willemze A; van Toorn L; Stoeken-Rijsbergen G; Levarht N; Drijfhout JW; Huizinga TW; Toes RE; Trouw LA Arthritis Res Ther; 2011; 13(6):R195. PubMed ID: 22129077 [TBL] [Abstract][Full Text] [Related]
38. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594 [TBL] [Abstract][Full Text] [Related]
39. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
40. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]